Pilot study introducing a new EQA scheme for Mycobacterium tuberculosis drug resistance
The Finnish EQA provider Labquality has introduced a new External Quality Assessment
(EQA) scheme for Mycobacterium tuberculosis, drug resistance, by performing a pilot study
named Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection, in June
2022.
(EQA) scheme for Mycobacterium tuberculosis, drug resistance, by performing a pilot study
named Mycobacterium tuberculosis, rifampicin and isoniazid, nucleic acid detection, in June
2022.
Fill in the form and download the poster
